Meiji Holdings Co Ltd 2015 Annual Report
The report presents FY2014 net sales of ¥1,161,152 million, operating income of ¥51,543 million, and net income of ¥30,891 million. It also highlights the acquisition of Medreich to expand pharmaceutical manufacturing and generic-drug sales in India, Asia, and Africa. Its CSR section focuses on personnel and the global environment, including a material balance and initiatives supporting women in the workplace.
Company: Meiji Holdings Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2015
Type: Annual Report
Pages: 86
Meiji Holdings Co Ltd
The report presents FY2014 net sales of ¥1,161,152 million, operating income of ¥51,543 million, and net income of ¥30,891 million. It also highlights the acquisition of Medreich to expand pharmaceutical manufacturing and generic-drug sales in India, Asia, and Africa. Its CSR section focuses on personnel and the global environment, including a material balance and initiatives supporting women in the workplace.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2015
Reporting Period
Apr 1, 2014 - Mar 31, 2015
Fiscal Year
2014
Type
Annual Report
Language
English
Pages
File Size
Standards & Assurance
No data available
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Total Waste
Women on Board
Employees